Correlation Between Aerovate Therapeutics and ALK Abell

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and ALK Abell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and ALK Abell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and ALK Abell AS, you can compare the effects of market volatilities on Aerovate Therapeutics and ALK Abell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of ALK Abell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and ALK Abell.

Diversification Opportunities for Aerovate Therapeutics and ALK Abell

-0.82
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Aerovate and ALK is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and ALK Abell AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ALK Abell AS and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with ALK Abell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ALK Abell AS has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and ALK Abell go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and ALK Abell

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the ALK Abell. In addition to that, Aerovate Therapeutics is 1.88 times more volatile than ALK Abell AS. It trades about -0.01 of its total potential returns per unit of risk. ALK Abell AS is currently generating about 0.04 per unit of volatility. If you would invest  1,400  in ALK Abell AS on September 19, 2024 and sell it today you would earn a total of  805.00  from holding ALK Abell AS or generate 57.5% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy99.8%
ValuesDaily Returns

Aerovate Therapeutics  vs.  ALK Abell AS

 Performance 
       Timeline  
Aerovate Therapeutics 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
ALK Abell AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ALK Abell AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's essential indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Aerovate Therapeutics and ALK Abell Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aerovate Therapeutics and ALK Abell

The main advantage of trading using opposite Aerovate Therapeutics and ALK Abell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, ALK Abell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ALK Abell will offset losses from the drop in ALK Abell's long position.
The idea behind Aerovate Therapeutics and ALK Abell AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Transaction History
View history of all your transactions and understand their impact on performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum